A real-world pharmacovigilance study of sacubitril\valsartan in older people: data mining of the FDA adverse event reporting system
Our study found potential new AEs signals and might provide important support for clinical monitoring and risk identification of Sacubitril\valsartan in elderly.
Authors
- Yangli Ye (ORCID: https://orcid.org/0000-0003-1875-3863)
- Zheng Kuai (ORCID: https://orcid.org/0000-0003-1866-5564)
- Guowen Tang
- Xiaoyi Zhang (ORCID: https://orcid.org/0000-0001-9732-1449)
- Quan Li (ORCID: https://orcid.org/0000-0001-9828-4408)
- Yu Hu (ORCID: https://orcid.org/0000-0003-3883-3887)
Institutions
- Fudan University (CN)
- Zhongshan Hospital (CN)
- Shanghai Institute of Hematology (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1080/14740338.2025.2464888
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00